HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The use of mouse models to understand and improve cognitive deficits in Down syndrome.

Abstract
Remarkable advances have been made in recent years towards therapeutics for cognitive impairment in individuals with Down syndrome (DS) by using mouse models. In this review, we briefly describe the phenotypes of mouse models that represent outcome targets for drug testing, the behavioral tests used to assess impairments in cognition and the known mechanisms of action of several drugs that are being used in preclinical studies or are likely to be tested in clinical trials. Overlaps in the distribution of targets and in the pathways that are affected by these diverse drugs in the trisomic brain suggest new avenues for DS research and drug development.
AuthorsIshita Das, Roger H Reeves
JournalDisease models & mechanisms (Dis Model Mech) Vol. 4 Issue 5 Pg. 596-606 (Sep 2011) ISSN: 1754-8411 [Electronic] England
PMID21816951 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Topics
  • Animals
  • Behavior, Animal
  • Brain (pathology, physiopathology)
  • Clinical Trials as Topic
  • Cognition Disorders (complications, physiopathology)
  • Disease Models, Animal
  • Down Syndrome (complications, drug therapy, physiopathology)
  • Humans
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: